Overview

Comparison Between Levosimendan and Adrenaline in CABG Patients

Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to compare between levosimendan and adrenaline in patients with pre-existing impaired systolic function (EF 30-40%), undergoing elective on-pump CABG, as regards hemodynamics and echocardiographic parameters.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Treatments:
Epinephrine
Epinephryl borate
Racepinephrine
Simendan
Criteria
Inclusion Criteria:

- ischemic hear disease

- age 18 and 60 years

- low left ventricular function (ejection fraction 30 - 40%),

- elective coronary artery bypass grafting (CABG) surgery

Exclusion Criteria:

- Age over 60 years

- Patients with end organ failure (renal, liver)

- Associated significant valve lesions

- Uncontrolled diabetes mellitus

- Emergency surgery